X0206 3 2021-10-01 0 0001635088 Roivant Sciences Ltd. ROIV 0001798550 Sumitomo Chemical Co., Ltd. 27-1, SHINKAWA 2-CHOME CHUO-KU, TOKYO M0 104-8260 JAPAN 0 0 1 0 0001446601 Dainippon Sumitomo Pharma Co Ltd 6-8 DOSHOMACHI 2-CHOME CHUO-KU, OSAKA M0 541-0045 JAPAN 0 0 1 0 Common Shares 86367360 I See Footnote Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon") directly owns 86,367,360 Common Shares. Sumitomo Dainippon is a 51.78% owned subsidiary of Sumitomo Chemical Co., Ltd. ("Sumitomo"). Sumitomo may be deemed to indirectly beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended) the reported securities that Sumitomo Dainippon owns. Sumitomo disclaims beneficial ownership of such reported securities except to the extent of its pecuniary interest therein. Sumitomo Dainippon Pharma Co., Ltd., By: /s/ Tsutomu Nakagawa, Name: Tsutomu Nakagawa, Title: Senior Director, Global Corporate Strategy 2021-10-01 Sumitomo Chemical Co., Ltd., By: /s/ Takeo Kitayama, Name: Takeo Kitayama, Title: Associate Officer, General Manager, Corporate Planning Office 2021-10-01